BPG - Quarterly Report Investor Webinar

Blackpearl Group Limited (NZX: BPG ) advises that it will host an investor webinar at 12.30pm NZDT (10.30am AEDT) on Wednesday, 15 October 2025, following the release of the Company’s Q2 FY26 results.

Chief Executive Officer Nick Lissette and Interim Chief Financial Officer Karen Cargill will provide a presentation to discuss the Company’s quarterly performance and key developments. They will be joined by Noah Loul, Head of B2B Rocket, and Trinity Lawry, Head of Pearl Diver, who will share updates on their respective business units, followed by a live Q&A session.

Register for the investor webinar via the link below:

https://us02web.zoom.us/webinar/register/WN_IhGU2joQShaRoZTOQnIraw

Participants are invited to submit questions prior to the event to simon@nwrcommunications.com.au, or alternatively, may submit questions via the Q&A function within Zoom during the webinar.

ENDS

• Quarterly Report Investor Webinar

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

Devon Funds Morning Note - 04 May 2026
MEL - Meridian joins global ranks of sustainable companies
May 5th Morning Report
ATM - a2MC recalls small volume of a2 Platinum USA label
CEN - Contact Chair to retire this year, new Chair appointed
May 1st Morning Report
GTK - Gentrack's Veovo Acquires Dubai Technology Partners
SML - Additional information following Bright Dairy announcement
April 30th Morning Report
Rua Bioscience Market Update